Related Experiment Video
Updated: Jan 1, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Link between omentin-1, obesity and insulin resistance in children: Findings from a longitudinal intervention study
Juliane Rothermel1, Nina Lass1, Andre Barth1
1Department of Pediatric Endocrinology, Diabetes and Nutrition Medicine, Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Datteln, Germany.
Insights
Omentin-1 levels are lower in children with obesity but increase with weight loss, suggesting it links obesity and insulin resistance. This adipokine
Area of Science:
- Endocrinology
- Pediatric Obesity
- Metabolic Health
Background:
- Omentin-1, an adipokine, is hypothesized to be inversely associated with obesity and insulin resistance.
- Understanding omentin-1's role in pediatric obesity is crucial for metabolic health interventions.
Purpose of the Study:
- To investigate the relationship between omentin-1 levels and parameters of fat mass, insulin resistance, lipids, and blood pressure in children with obesity.
- To examine the longitudinal changes in omentin-1 concentrations in response to a lifestyle intervention in children with obesity.
Main Methods:
- Analyzed omentin-1 concentrations in normal-weight children and children with obesity over a one-year lifestyle intervention.
- Measured various metabolic parameters including body composition, insulin resistance (HOMA-IR), lipids, and blood pressure at baseline and follow-up.
Main Results:
- Omentin-1 concentrations were significantly lower in children with obesity compared to normal-weight children.
- Omentin-1 levels increased significantly with substantial weight loss during and after the intervention.
- Omentin-1 showed a significant negative association with insulin resistance (HOMA-IR) in both cross-sectional and longitudinal analyses.
Conclusions:
- Omentin-1 levels are reversibly decreased in pediatric obesity.
- Omentin-1 may serve as a crucial link between obesity and the development of insulin resistance in children.
- Weight loss interventions can positively impact omentin-1 levels, highlighting its potential as a therapeutic target.
Objective:
The adipokine omentin-1 has been suggested to be inversely associated with obesity and insulin resistance in humans. We studied the relationships between omentin-1, parameters of fat mass, insulin resistance, lipids and blood pressure in children with obesity in a longitudinal study.
Methods:
We analysed omentin-1 concentrations in 23 normal-weight children and in 82 children with obesity participating in a one-year lifestyle intervention. In the children with obesity, omentin-1, bioactive and conventional leptin, thyroid hormones (thyroid-stimulating hormone, free thyroxine 4, free triiodothyronine), body mass index, waist circumference, body fat based on skin-fold measurements and bioimpedance analyses, lipids, insulin resistance as homeostatic model assessment of insulin resistance (HOMA-IR) and blood pressure were determined at baseline and 1 year later. Furthermore, we measured omentin-1 concentrations 1 year after the end of the lifestyle intervention.
Results:
The omentin-1 concentrations were significantly (P = .008) lower in children with obesity compared to normal-weight children (296 ± 108 ng ml-1 vs. 232 ± 99 ng ml-1 ). Omentin-1 concentrations increased significantly (P < .001) in children with obesity and substantial weight loss (35 ± 55 ng ml-1 ), while omentin-1 concentrations did not change significantly (P = .750) in children with obesity without weight loss (-5 ± 108 ng ml-1 ) during the intervention. Substantial weight loss after the end of intervention led to a significant (P < .001) increase of omentin-1 concentrations (+64 ± 14 ng ml-1 ). Omentin-1 was significantly and negatively associated with HOMA-IR both in cross-sectional (r = -.27, P = .006) and longitudinal analyses (r = -.33, P = .001). Omentin-1 concentrations were not related to pubertal stage, sex or thyroid hormones.
Conclusions:
Our data do support the hypothesis that omentin-1 is reversibly decreased in obesity and is a link between obesity and insulin resistance.
Related Concept Videos
Obesity
Regulation of Food Intake

